---
annotations:
- type: Pathway Ontology
  value: vascular endothelial growth factor signaling pathway
authors:
- MaintBot
- Khanspers
- ReactomeTeam
- Anwesha
description: In normal development vascular endothelial growth factors (VEGFs) are
  crucial regulators of vascular development during embryogenesis (vasculogenesis)
  and blood-vessel formation in the adult (angiogenesis). In tumor progression, activation
  of VEGF pathways promotes tumor vascularization, facilitating tumor growth and metastasis.
  Abnormal VEGF function is also associated with inflammatory diseases including atherosclerosis,
  and hyperthyroidism. The members of the VEGF and VEGF-receptor protein families
  have distinct but overlapping ligand-receptor specificities, cell-type expression,
  and function. VEGF-receptor activation in turn regulates a network of signaling
  processes in the body that promote endothelial cell growth, migration and survival
  (Hicklin and Ellis, 2005; Shibuya and Claesson-Welsh, 2006).<br>Molecular features
  of the VGF signaling cascades are outlined in the figure below (from Olsson et al.
  2006; Nature Publishing Group). Tyrosine residues in the intracellular domains of
  VEGF receptors 1, 2,and 3 are indicated by dark blue boxes; residues susceptible
  to phosphorylation are numbered. A circled R indicates that phosphorylation is regulated
  by cell state (VEGFR2), by ligand binding (VEGFR1), or by heterodimerization (VEGFR3).
  Specific phosphorylation sites (boxed numbers) bind signaling molecules (dark blue
  ovals), whose interaction with other cytosolic signaling molecules (light blue ovals)
  leads to specific cellular (pale blue boxes) and tissue-level (pink boxes) responses
  in vivo. Signaling cascades whose molecular details are unclear are indicated by
  dashed arrows. DAG, diacylglycerol; EC, endothelial cell; eNOS, endothelial nitric
  oxide synthase; FAK, focal adhesion kinase; HPC, hematopoietic progenitor cell;
  HSP27, heat-shock protein-27; MAPK, mitogen-activated protein kinase; MEK, MAPK
  and ERK kinase; PI3K, phosphatidylinositol 3' kinase; PKC, protein kinase C; PLCgamma,
  phospholipase C-gamma; Shb, SH2 and beta-cells; TSAd, T-cell-specific adaptor.<br>In
  the current release, the first events in these cascades - the interactions between
  VEGF proteins and their receptors - are annotated.  View original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=194138
  Reactome].
last-edited: 2021-01-25
organisms:
- Homo sapiens
redirect_from:
- /index.php/Pathway:WP1919
- /instance/WP1919
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP1919.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: In normal development vascular endothelial growth factors (VEGFs) are
    crucial regulators of vascular development during embryogenesis (vasculogenesis)
    and blood-vessel formation in the adult (angiogenesis). In tumor progression,
    activation of VEGF pathways promotes tumor vascularization, facilitating tumor
    growth and metastasis. Abnormal VEGF function is also associated with inflammatory
    diseases including atherosclerosis, and hyperthyroidism. The members of the VEGF
    and VEGF-receptor protein families have distinct but overlapping ligand-receptor
    specificities, cell-type expression, and function. VEGF-receptor activation in
    turn regulates a network of signaling processes in the body that promote endothelial
    cell growth, migration and survival (Hicklin and Ellis, 2005; Shibuya and Claesson-Welsh,
    2006).<br>Molecular features of the VGF signaling cascades are outlined in the
    figure below (from Olsson et al. 2006; Nature Publishing Group). Tyrosine residues
    in the intracellular domains of VEGF receptors 1, 2,and 3 are indicated by dark
    blue boxes; residues susceptible to phosphorylation are numbered. A circled R
    indicates that phosphorylation is regulated by cell state (VEGFR2), by ligand
    binding (VEGFR1), or by heterodimerization (VEGFR3). Specific phosphorylation
    sites (boxed numbers) bind signaling molecules (dark blue ovals), whose interaction
    with other cytosolic signaling molecules (light blue ovals) leads to specific
    cellular (pale blue boxes) and tissue-level (pink boxes) responses in vivo. Signaling
    cascades whose molecular details are unclear are indicated by dashed arrows. DAG,
    diacylglycerol; EC, endothelial cell; eNOS, endothelial nitric oxide synthase;
    FAK, focal adhesion kinase; HPC, hematopoietic progenitor cell; HSP27, heat-shock
    protein-27; MAPK, mitogen-activated protein kinase; MEK, MAPK and ERK kinase;
    PI3K, phosphatidylinositol 3' kinase; PKC, protein kinase C; PLCgamma, phospholipase
    C-gamma; Shb, SH2 and beta-cells; TSAd, T-cell-specific adaptor.<br>In the current
    release, the first events in these cascades - the interactions between VEGF proteins
    and their receptors - are annotated.  View original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=194138
    Reactome].
  keywords:
  - MAPKAP kinase
  - 'ABI1 '
  - AKT:PIP3
  - 'ITPR1 '
  - 'PRKCD '
  - PLCG1
  - 'p-Y419-SRC '
  - VEGFA:p-6Y-VEGFR2:p-SHB:p-5Y-PTK2:SRC-1
  - 'ITGB3 '
  - 'p-T308,S473-AKT1 '
  - dimer:NCK1,NCK2:FYN
  - NRP2
  - 'ROCK1 '
  - 'CTNND1 '
  - H2O
  - PDPK1:PIP3
  - VEGFR1 dimer:VEGFA,
  - '2'
  - O2
  - NCK1,NCK2
  - 'ELMO1 '
  - cascade
  - 'NCK2 '
  - 'aflibercept '
  - VEGFA inhibitors
  - GTP
  - p-S1177-eNOS:CaM:HSP90:p-AKT1
  - Ca2+
  - L-Arg
  - 'MAPK13 '
  - 'MTOR '
  - 'DOCK1 '
  - TORC2 complex
  - dimer:SH2D2A
  - VEGFA:p-6Y-VEGFR2:Integrin alphaVbeta3:PTK2B
  - eNOS:CaM:HSP90:p-AKT1
  - RAF/MAP kinase
  - 'p-Y172-VAV2 '
  - 'Mg2+ '
  - VEGFB, PGF dimers
  - 'p-T410,T563-PRKCZ '
  - 'Activated ROCK2 '
  - 'CDC42 '
  - VEGFA-165 dimer
  - 'p-Y31,Y118-PXN '
  - 'FAD '
  - dimer:NCK1,NCK2:p-S21,Y420-FYN
  - 'ABI2 '
  - dimer:p-4Y-PLCG1
  - dimer
  - 'ITPR3 '
  - 'PIK3CB '
  - dimer:PI3K
  - 'GTP '
  - 'p-5Y,S732-PTK2 '
  - complex
  - NADPH
  - 'BCAR1 '
  - 'AKT1 '
  - ATP
  - VEGFA:p-6Y-VEGFR2:NCK:p-S21,Y420-FYN:PAK2:CDC42:GTP
  - PDPK1
  - 'PRKCA '
  - 'p-T305,S472-AKT3 '
  - 'NAD+ '
  - 'MAPK14 '
  - 'RHOA '
  - 'PAK1 '
  - AAMP gene
  - VEGF dimer
  - p-VAV
  - 'p-T500-PRKCB '
  - dimer:NCK1,NCK2:p-S21,Y420-FYN:PAK2
  - 'WASF3 '
  - 'CYFIP2 '
  - 'p-Y130,S141,T402-PAK2 '
  - 'p-T497-PRKCA '
  - DOCK180:ELMO1,ELMO2
  - 'p-T410-PRKCZ '
  - 'CRK '
  - 'MAPKAPK2 '
  - 'p-Y12-BCAR1 '
  - 'NCKAP1L '
  - Protein kinase A
  - RHOA:GTP:ROCK1,ROCK2
  - 'ROCK2 '
  - 'p-S141,T402-PAK2 '
  - 'PRR5 '
  - CDC42:GTP
  - VEGFR3 dimer:VEGFC,
  - WAVE Regulatory
  - 'RICTOR '
  - NADP+
  - p-PKC
  - 'MAPK11 '
  - VEGFA:p-6Y-VEGFR2:pS-SHB:p-5Y,S732-PTK2:SRC-1:HSP90AA1
  - 'p-S473-AKT1 '
  - VEGFA:p-6Y-VEGFR2:p-SHB:p-6Y,S732-PTK2:SRC-1:HSP90AA1:BCAR1
  - Unknown GEF
  - VEGFA:p-6Y-VEGFR2:p-SHB:p-6Y,S732-PTK2:SRC-1:HSP90AA1
  - CRK
  - 'BH4 '
  - 'p-Y174-VAV1 '
  - VEGFA:p-6Y-VEGFR2:SH2D2A:p-Y418-SRC-1:p-Y772,Y814-AXL
  - 'Zn2+ '
  - 'VAV3 '
  - 'FLT4 '
  - VEGFA,VEGFB,PGF
  - eNOS:Caveolin-1:CaM:HSP90
  - 'ITPR2 '
  - CALM1:4xCa2+
  - 'HSP90AA1 '
  - RASA1
  - L-Cit
  - dimer:SHB
  - 'ELMO2 '
  - 'PIK3R2 '
  - 'PRKCB '
  - SHB
  - BCAR1
  - 'NCF4 '
  - FLT4
  - 'PRKACB '
  - 'RASA1 '
  - NOX2
  - 'Ca2+ '
  - 'p-S154,T436-PAK3 '
  - 'p-T497,T638,S657-PRKCA '
  - dimer:PLCG1
  - ROCK1,ROCK2
  - RHOA:GTP:Mg2+:Activated ROCK1,ROCK2
  - 'FIGF '
  - RASA1:p21
  - 'p-T507-PRKCD '
  - NOX2 complex
  - ADP
  - VEGFA:p-6Y-VEGFR2:SH2D2A:p-Y418-SRC-1:p-Y772,Y814-AXL:PI3K
  - 'AXL '
  - cofactor)
  - 'ITGAV(31-1048) '
  - HSP90AA1
  - 'VEGFA '
  - VEGFA:p-6Y-VEGFR2:p-SHB:p-7Y-PTK2:SRC-1:HSP90:p-12Y-BCAR1
  - dimer:VEGFA
  - 'NO'
  - 'pS-SHB '
  - dimer:VEGFR2
  - IP3 receptor
  - BH4
  - VEGFA:p-6Y-VEGFR2:p-SHB:p-7Y-PTK2:SRC-1:HSP90:p-12Y-BCAR1,VEGFA:p-6Y-VEGFR2:p-SHB:p-7Y-PTK2:SRC-1:HSP90:p-Y31,Y118-PXN
  - p-S15,S78,S82-HSP27
  - VEGFA:p-6Y-VEGFR2:SHC2
  - 'I(1,4,5)P3 '
  - 'p-6Y,S732-PTK2 '
  - PI(4,5)P2
  - VEGFD dimers
  - 'PRKACG '
  - 'p-S21,Y420-FYN '
  - NRP1:VEGFR2 dimer
  - MAP kinase p38 (Mg2+
  - VEGFA-165
  - PI(3,4,5)P3
  - dimer:PI3K/VEGFA:p-6Y-VEGFR2:SH2D2A:p-Y418-SRC-1:p-Y772,Y814-AXL:PI3K
  - VEGF
  - eNOS:Caveolin-1:CaM
  - F-actin
  - 'PAK2 '
  - 'AHCYL1 '
  - dimer:NCK1,NCK2:p-Y420-FYN
  - '2xPalmC-MyrG-p-S1177-NOS3 '
  - p-S225-SPHK1
  - 'NRP1 '
  - inhibitors
  - 'MAPKAP1 '
  - H+
  - 'PRKACA '
  - CDC42-GDP
  - p-S665-VE-cadherin-Catenin complex
  - VEGFA:p-6Y-VEGFR2:p-SHB:p-Y397-PTK2
  - dimer:SH2D2A:SRC-1
  - 'CYBB '
  - PIP3:VAV1,2,3
  - 'NCF1 '
  - AAMP
  - 'MAPK12 '
  - VEGFC,VEGFD dimers
  - 'beta-catenin '
  - SRC-1
  - 'p-T180,Y182-MAPK14 '
  - p21 RAS:GTP
  - Phospho-MAP kinase
  - 'PGF '
  - 'PLCG1 '
  - p-S-AKT:PIP3
  - CRK:DOCK180:ELMO1,ELMO2:VEGFA:p-6Y-VEGFR2:p-SHB:p-7Y-PTK2:SRC-1:HSP90:p-12Y-BCAR1,VEGFA:p-6Y-VEGFR2:p-SHB:p-7Y-PTK2:SRC-1:HSP90:p-Y31,Y118-PXN
  - 'p-4Y-PLCG1 '
  - 'p-S,2T-MAPKAPK3 '
  - AHCYL1:NAD+:ITPR1:I(1,4,5)P3 tetramer
  - 'PAK3 '
  - 'AKT3 '
  - 'p-6Y-VEGFR2 '
  - RAC1:GDP
  - 'NCKAP1 '
  - p-S272,T222,T334-MAPKAPK2, p-S,2T-MAPKAPK3
  - WRC:IRSp53/58:RAC1:GTP:PIP3
  - p-T,p-S-AKT
  - Complex
  - VEGFA:p-6Y-VEGFR2:Integrin alphaVbeta3:p-Y402-PTK2B
  - 'BAIAP2 '
  - NRP1
  - VEGFA:p-6Y-VEGFR2:p-SHB:p-7Y-PTK2:SRC-1:HSP90:p-Y31,Y118-PXN
  - 'CAV1 '
  - catalytic subunit
  - eNOS:Caveolin-1
  - complex:RAC1:GTP
  - 'VEGFR2 '
  - SH2D2A
  - '2xPalmC-MyrG-NOS3 '
  - SPHK1
  - HSP27
  - VEGFA:p-6Y-VEGFR2:Integrin alphaVbeta3
  - 'p-T180,Y182-MAPK11 '
  - 'MAPKAPK3 '
  - dimer:p-S-SHB
  - 'S-Farn-Me-PalmS KRAS4A '
  - 'PTK2B '
  - DAG:active PKC:Ca+2
  - 'PDPK1 '
  - RAS:GTP:SPG
  - 'p-S472-AKT3 '
  - S1P
  - 'NCF2 '
  - 'PRKCZ '
  - p-T308,S473-AKT1
  - 'PI(3,4,5)P3 '
  - PTK2
  - p-S-AKT:PDPK1:PIP3
  - 'BRK1 '
  - 'SHB '
  - PKCA,PKCB,PKCD,PKCZ
  - p-S1177-eNOS:CaM:HSP90:p-AKT1:BH4
  - 'CYBA '
  - 'VEGFA-165 '
  - BAIAP2
  - VEGFR1
  - 'FMN '
  - ADMA
  - 'F-actin '
  - 'S-Farn-Me KRAS4B '
  - ITPR:I(1,4,5)P3
  - CAV1
  - VAV1,2,3
  - 'PTK2 '
  - 'CALM1 '
  - GDP
  - p38 (Mg2+ cofactor)
  - dimer:NCK1,NCK2
  - VEGFA:p-6Y-VEGFR2:NCK:p-S21,Y420-FYN:p-2Y-PAK2:CDC42:GTP
  - tetramer
  - 'TRIB3 '
  - VEGFA:p-6Y-VEGFR2:p-SHB:p-7Y-PTK2:SRC-1:HSP90:p-12Y-BCAR1/p-Y31,Y118-PAX:CRK
  - DAGs
  - 'SH2D2A '
  - 'VAV2 '
  - VEGFA:p-6Y-VEGFR2:SH2D2A:p-Y418-SRC-1:AXL
  - 'HSBP1 oligomer '
  - VEGFA
  - 'GDP '
  - family:PIP3:RAC1:GTP:PAK 1-3
  - VEGFA:p-6Y-VEGFR2:p-SHB:p-5Y-PTK2:SRC-1:HSP90AA1
  - 'p-Y397-PTK2 '
  - SHC2
  - dimer:p-6Y-VEGFR2
  - 'SHC2 '
  - 'p-S144,T423-PAK1 '
  - 'p-S474-AKT2 '
  - 'p-Y173-VAV3 '
  - VE-cadherin-Catenin
  - 'VEGFB '
  - 'NCK1 '
  - 'JUP '
  - VEGFA:p-6Y-VEGFR2:p-SHB:p-7Y-PTK2:SRC-1:HSP90:PXN
  - AXL
  - p-PKCA,p-PKCB,p-PKCZ,p-PKCD
  - 'p-T500,T642,S661-PRKCB '
  - CALM1
  - p-S,T-PAK1,2,3
  - VEGFA:p-6Y-VEGFR2:SH2D2A:p-Y418-SRC-1
  - PAK2 dimer
  - PTK2B
  - VEGFA:p-6Y-VEGFR2:NCK:p-S21,Y420-FYN:p-3Y-PAK2:CDC42:GTP
  - oligomer:F-actin
  - 'THEM4 '
  - homotetramer
  - VEGFR2
  - NRP2:VEGFR1 dimer
  - 'S-Farn-Me-2xPalmS HRAS '
  - p-VAV family:PIP3
  - 'VEGFC '
  - x
  - 'p-T309,S474-AKT2 '
  - p-4Y-PLCG1
  - VEGFA:p-6Y-VEGFR2:p-SHB:PTK2
  - 'DAGs '
  - PAK1,2,3 dimer
  - 'VAV1 '
  - VEGFR2:VEGFA,C,D
  - 'p-Y420-FYN '
  - PXN
  - 'SPG '
  - 'AKT2 '
  - 'p-S272,T222,T334-MAPKAPK2 '
  - VEGFA:p-6Y-VEGFR2:p-SHB:p-Y397-PTK2:SRC-1
  - O2.-
  - 'PIK3CA '
  - 'CTNNA1 '
  - 'heme '
  - AKT:PIP3:THEM4/TRIB3
  - eNOS:CaM:HSP90
  - 'RAC1 '
  - 'PXN '
  - 'p-T507,S645,S664-PRKCD '
  - 'Activated ROCK1 '
  - 'p-Y772,Y814-AXL '
  - VEGFA dimer
  - family:PIP3:RAC1:GTP
  - 'SRC-1 '
  - FYN
  - family:PIP3:RAC1:GDP
  - I(1,4,5)P3
  - VEGFA,C,D dimers
  - PI3K
  - 'WASF2 '
  - dimers
  - RHOA:GTP
  - Integrin alphaVbeta3
  - 'S-Farn-Me PalmS NRAS '
  - RAC1:GTP
  - 'FYN '
  - 'NRP2 '
  - 'p-5Y-PTK2 '
  - 'VE-cadherin '
  - 'PIK3R1 '
  - 'p-S665-VE-cadherin '
  - 'VEGFR1 '
  - 'CYFIP1 '
  - 'WASF1 '
  - 'MLST8 '
  license: CC0
  name: Signaling by VEGF
seo: CreativeWork
title: Signaling by VEGF
wpid: WP1919
---